JP2023551537A5 - - Google Patents

Info

Publication number
JP2023551537A5
JP2023551537A5 JP2023533232A JP2023533232A JP2023551537A5 JP 2023551537 A5 JP2023551537 A5 JP 2023551537A5 JP 2023533232 A JP2023533232 A JP 2023533232A JP 2023533232 A JP2023533232 A JP 2023533232A JP 2023551537 A5 JP2023551537 A5 JP 2023551537A5
Authority
JP
Japan
Prior art keywords
drug
autoimmune
gene
cdna
autoimmune drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023533232A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023551537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/061033 external-priority patent/WO2022115714A1/en
Publication of JP2023551537A publication Critical patent/JP2023551537A/ja
Publication of JP2023551537A5 publication Critical patent/JP2023551537A5/ja
Pending legal-status Critical Current

Links

JP2023533232A 2020-11-30 2021-11-29 マイクロニードルデバイスおよび方法、ならびに皮膚疾病アッセイ Pending JP2023551537A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063119511P 2020-11-30 2020-11-30
US63/119,511 2020-11-30
PCT/US2021/061033 WO2022115714A1 (en) 2020-11-30 2021-11-29 Microneedle devices and methods, and skin condition assays

Publications (2)

Publication Number Publication Date
JP2023551537A JP2023551537A (ja) 2023-12-08
JP2023551537A5 true JP2023551537A5 (cg-RX-API-DMAC7.html) 2024-12-06

Family

ID=81754928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023533232A Pending JP2023551537A (ja) 2020-11-30 2021-11-29 マイクロニードルデバイスおよび方法、ならびに皮膚疾病アッセイ

Country Status (10)

Country Link
US (3) US20230383352A1 (cg-RX-API-DMAC7.html)
EP (2) EP4756039A3 (cg-RX-API-DMAC7.html)
JP (1) JP2023551537A (cg-RX-API-DMAC7.html)
KR (1) KR20230165746A (cg-RX-API-DMAC7.html)
CN (1) CN116782827A (cg-RX-API-DMAC7.html)
AU (1) AU2021385427A1 (cg-RX-API-DMAC7.html)
CA (1) CA3199737A1 (cg-RX-API-DMAC7.html)
ES (1) ES3072194T3 (cg-RX-API-DMAC7.html)
IL (1) IL303198A (cg-RX-API-DMAC7.html)
WO (1) WO2022115714A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230165746A (ko) 2020-11-30 2023-12-05 민데라 코포레이션 마이크로니들 디바이스 및 방법, 및 피부 병태 어세이
KR102958277B1 (ko) * 2024-03-13 2026-04-30 주식회사 브이티 플라즈마 공정을 이용하여 하이드롤라이즈드해면을 가공하는 방법 및 플라즈마 공정 처리된 하이드롤라이즈드해면을 포함하는 화장료 조성물
CN119367261B (zh) * 2024-10-31 2025-05-23 南方医科大学皮肤病医院(广东省皮肤病医院、广东省皮肤性病防治中心、中国麻风防治研究中心) 一种用于银屑病治疗的负载药物的微针贴片及其制备方法

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
JP4647098B2 (ja) 1997-12-31 2011-03-09 メドトロニック ミニメド インコーポレイテッド 挿入セットのための挿入装置
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
CA2347064A1 (en) 1998-10-15 2000-04-20 Toyo Kohan Co., Ltd. Supports for immobilizing dna or the like
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6511463B1 (en) 1999-11-18 2003-01-28 Jds Uniphase Corporation Methods of fabricating microneedle arrays using sacrificial molds
US6692965B1 (en) 1999-11-23 2004-02-17 Chromocell Corporation Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
ATE295200T1 (de) 1999-12-10 2005-05-15 Alza Corp Hautbehandlungsvorrichtung zur verlängerten transdermalen verabreichung von medikamenten
DE60024312T2 (de) 1999-12-10 2006-08-17 Alza Corp., Mountain View Transdermale Wirkstoffabgabe von makromolekularen Wirkstoffen und Vorrichtung hierfür
KR100704528B1 (ko) 2000-04-04 2007-04-10 도요 고한 가부시키가이샤 표면 처리층이 형성된 슬라이드 글라스
KR100544850B1 (ko) 2000-08-08 2006-01-24 도요 고한 가부시키가이샤 기판의 활성화 키트 및 이를 사용한 dna 등의 검출 방법
US6749575B2 (en) 2001-08-20 2004-06-15 Alza Corporation Method for transdermal nucleic acid sampling
US6533949B1 (en) 2000-08-28 2003-03-18 Nanopass Ltd. Microneedle structure and production method therefor
EP1341442B1 (en) * 2000-10-13 2005-06-29 Alza Corporation Microblade array impact applicator
ES2317940T3 (es) 2000-10-13 2009-05-01 Alza Corporation Dispositivo de retencion para un elemento de microsalientes para aplicador de impactos.
JP3605039B2 (ja) 2001-01-09 2004-12-22 株式会社日立製作所 核酸マイクロアレイ、その製造方法及びそれを用いた核酸検出方法
WO2002072889A2 (en) 2001-01-12 2002-09-19 Applera Corporation Methods and compositions for microarray control
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
WO2003016574A1 (en) 2001-08-16 2003-02-27 Zhifeng Shao Analysis of gene expression profiles using sequential hybridization
US6881203B2 (en) 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
EP1480712A2 (en) 2001-09-28 2004-12-01 BioValve Technologies, Inc. Switchable microneedle arrays and systems and methods relating to same
US20030211528A1 (en) 2002-03-12 2003-11-13 Norman Iscove Exponential amplification of sub-picogram nucleic acid samples with retention of quantitative representation
AU2012213965B2 (en) 2003-09-11 2015-10-22 Labrador Diagnostics Llc Medical device for analyte monitoring and drug delivery
WO2005082593A1 (en) 2004-02-17 2005-09-09 Avery Dennison Corporation Method of making microneedles
EP1720015A1 (en) 2004-03-17 2006-11-08 Matsushita Electric Industrial Co., Ltd. Process for producing biochip, probe solution, and biochip
EP3329960A1 (en) * 2004-06-10 2018-06-06 3M Innovative Properties Company Patch application device and kit
US7132054B1 (en) * 2004-09-08 2006-11-07 Sandia Corporation Method to fabricate hollow microneedle arrays
WO2006031500A2 (en) 2004-09-10 2006-03-23 Becton, Dickinson And Company Reconstituting infusion device
US20060134661A1 (en) 2004-10-12 2006-06-22 Richard Essner Treatment of cancer and compositions
JP5133697B2 (ja) * 2004-12-10 2013-01-30 スリーエム イノベイティブ プロパティズ カンパニー 医療用デバイス
US8249814B2 (en) 2005-10-21 2012-08-21 Genenews Inc. Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
EP2489745B1 (en) 2006-06-05 2017-01-11 California Institute Of Technology Real time micro arrays
EP3796002B1 (en) 2006-07-14 2023-11-22 The Regents of The University of California Cancer biomarkers and methods of use thereof
EP2052088A2 (en) * 2006-08-02 2009-04-29 Genizon Biosciences Genemap of the human genes associated with psoriasis
EP2094870A4 (en) 2006-11-03 2010-05-05 Univ Texas BIFUNCTIONAL PREDICTORS OF SENSITIVITY AND RESISTANCE TO CANCER THERAPY
ES2473620T3 (es) 2007-02-06 2014-07-07 Hisamitsu Pharmaceutical Co., Inc. Dispositivo de microagujas para el diagnóstico de una alergia
US20100105104A1 (en) 2007-03-05 2010-04-29 On-Chip Cellomics Consortium Chip for sampling cell component, system for analyzing cell component and method of analyzing cell component using the same
WO2008148392A1 (en) 2007-06-04 2008-12-11 In Situ Rcp A/S Enzyme activity assay using rolling circle amplification
US8609041B2 (en) 2007-08-06 2013-12-17 Samir Mitragotri Apparatus for solubilizing tissue
CA2735575A1 (en) 2007-08-10 2009-02-19 Wayne State University Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system
CA2706404C (en) 2007-11-21 2017-04-11 Bioserentach Co., Ltd. Preparation for body surface application and preparation for body surface application-holding sheet
EP2294415A4 (en) 2008-05-23 2011-10-05 Univ Queensland ANALYTIC DETECTION BY MEANS OF MICRONADELPFLASTER WITH ANALYTICAL REAGENT
EP3881874A1 (en) 2008-09-15 2021-09-22 DEKA Products Limited Partnership Systems and methods for fluid delivery
US8545806B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US20110288389A9 (en) 2009-03-02 2011-11-24 Seventh Sense Biosystems, Inc. Oxygen sensor
WO2010128158A1 (en) 2009-05-08 2010-11-11 Novartis Ag Diagnostic biomarkers for fibrotic disorders
EP2275164A1 (en) 2009-07-15 2011-01-19 Debiotech S.A. Multichannel micro-needles
CN102958556B (zh) 2010-04-28 2017-02-15 金伯利-克拉克环球有限公司 细胞相互作用增强的纳米图案化医疗装置
US20110294996A1 (en) 2010-05-31 2011-12-01 Scheiber Lane Bernard Quantum unit of inheritance
JP2013531499A (ja) * 2010-06-15 2013-08-08 セルジーン コーポレイション 乾癬の治療のためのバイオマーカー
CA2819399C (en) 2010-12-03 2021-03-23 Kabushiki Kaisha Yakult Honsha Marker for determination of sensitivity to triplet combination anti-cancer agent
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
WO2014078545A1 (en) * 2012-11-16 2014-05-22 3M Innovative Properties Company Force-controlled applicator for applying a microneedle device to skin
EP2931356B1 (en) * 2012-12-14 2019-03-06 Mindera Corporation Methods and devices for detection and acquisition of biomarkers
CN106456744A (zh) * 2014-04-01 2017-02-22 鲁比厄斯治疗法股份有限公司 用于免疫调节的方法和组合物
WO2015164840A1 (en) * 2014-04-24 2015-10-29 Georgia Tech Research Corporation Microneedles and methods of manufacture thereof
MX2018003376A (es) 2015-09-17 2018-08-15 Amgen Inc Prediccion de la respuesta clinica a antagonistas de il23 mediante el uso de biomarcadores de la via de il23.
GB201521357D0 (en) * 2015-12-03 2016-01-20 Univ Liverpool Methods for predicting response to anti-TNF therapy
WO2017112536A1 (en) 2015-12-22 2017-06-29 Amgen Inc. Ccl20 as a predictor of clinical response to il23-antagonists
CN116726371A (zh) * 2016-08-03 2023-09-12 沃达瑞公司 微阵列和方法
US12433510B2 (en) * 2017-12-21 2025-10-07 Georgia Tech Research Corporation Methods and systems for improved collection of interstitial fluid
WO2019178546A1 (en) * 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
WO2019191679A1 (en) 2018-03-30 2019-10-03 Incyte Corporation Biomarkers for inflammatory skin disease
EP3975841A1 (en) * 2019-05-30 2022-04-06 Massachusetts Institute of Technology Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids
KR20220084305A (ko) * 2019-10-04 2022-06-21 더 리젠츠 오브 더 유니버시티 오브 미시간 건선의 치료에서 항-종양 괴사 인자 치료법에 대한 반응성을 결정하는 방법
WO2022115383A1 (en) 2020-11-24 2022-06-02 Empirico Inc. Treatment of sos2 related diseases and disorders
KR20230165746A (ko) 2020-11-30 2023-12-05 민데라 코포레이션 마이크로니들 디바이스 및 방법, 및 피부 병태 어세이

Similar Documents

Publication Publication Date Title
Gerstmayer et al. Identification of RELMγ, a novel resistin-like molecule with a distinct expression pattern☆
JP2021072774A (ja) 染色体相互作用の部位を用いた検出法
JP7245255B2 (ja) がん治療の有効性を予測するためのシステムおよび方法
Hoh et al. The p53MH algorithm and its application in detecting p53-responsive genes
US20220002782A1 (en) Method for preparing nucleic acid derived from skin cell of subject
JP2025023316A (ja) クローン病に関連するtnfsf15及びdcr3の変異体
JP2025515307A5 (cg-RX-API-DMAC7.html)
Fan et al. Identification of potential novel biomarkers and therapeutic targets involved in human atrial fibrillation based on bioinformatics analysis
JP2022513399A (ja) 無細胞メッセンジャーrnaを使用した骨髄の特徴付け
Hibsh et al. De novo transcriptome assembly databases for the central nervous system of the medicinal leech
WO2024186563A1 (en) Methods and systems for determining gene sets for diagnosis and treatment of disease states
Ellisen et al. Cascades of transcriptional induction during human lymphocyte activation
CN116782827A (zh) 微针装置和方法以及皮肤病状测定
Taylor et al. Dynamic and physical clustering of gene expression during epidermal barrier formation in differentiating keratinocytes
Yao et al. RNA-seq reveal RNA binding protein GNL3 as a key mediator in the development of psoriasis vulgaris by regulating the IL23/IL17 axis
US20260117297A1 (en) Longitudinal Gene Expression Analysis of Inflammatory Skin Diseases
CN107653309A (zh) Mir135hg在调控心血管系统中的应用
CN112863604B (zh) 一种预测肿瘤间质化机制及治疗敏感性的方法
CN105506155A (zh) 检测长链非编码rna loc284454表达量的试剂的应用
KR102811567B1 (ko) 마이크로바이옴-유래 동반 진단을 위한 방법 및 시스템
JP2017079730A (ja) 関節リウマチに対する生物学的製剤の治療効果を予測する方法、およびそれを用いて最適な薬剤を選択する方法
JP2004524801A (ja) Are含有遺伝子の発現を同定および分析するための方法
Xu et al. Bioinformatics analysis reveals micrornas regulating biological pathways in exercise‐induced cardiac physiological hypertrophy
WO2024102200A9 (en) Methods and systems for evaluation of lupus based on ancestry-associated molecular pathways
CN108733977A (zh) 真核生物保守转录因子结合位点聚集区tfcr的识别方法与应用